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Presented herein, is the case of a 73-year-old 
male who underwent an uneventful transcatheter 
aortic valve replacement (TAVR) for severe non-
-rheumatic aortic valve stenosis. Protamine was ad-
ministered intravenously to reverse anticoagulation, 
followed by large bore sheath removal. Immediately 
following protamine infusion, the patient developed 
profound hypotension with a systolic blood pres-
sure of 60 mmHg. Transthoracic echocardiogram 
was being performed simultaneously to assess the 
prosthetic aortic valve which revealed a significant 
dilation of the right ventricle (RV) with reduction 
in RV systolic function (Fig. 1C, D). Clinical as-
sessment of the patient ruled out arteriotomy site 
bleeding or valvular dysfunction as the cause of 
hypotension. Approximately 90 s later, the patient’s 
hemodynamics recovered spontaneously without 
the use of vasopressors or any further interven-
tion. Repeat echocardiogram revealed RV size 
and function had returned to baseline which were 
normal (Fig. 1A, B). While the precise mechanism 
of protamine induced systemic hypotension has not 
been determined, vasodilation or protamine induced 
pulmonary vasoconstriction secondary to an anaphy-
lactic response may occur as a result of histamine 
release and increased nitric oxide production. This 
case presents a novel finding of protamine induced 
hypotension without features of shock observed 
during a TAVR procedure along with RV dilation 
that resolved spontaneously. The patient had a re-
peat echocardiogram at 3-month follow-up which 
showed normal biventricular size and function, 
normal pulmonary artery pressures and prosthetic 
valve function. We recommend that the RV should 
be adequately monitored during protamine admin-
istration and echocardiograms should be recorded 
before and after protamine administration to assess 
for sustained RV compromise.  
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Figure 1. Transthoracic echocardiogram images at baseline (A, B) and after protamine administration (C, D). Image 
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